A benefit cost analysis of dry-cow mastitis therapy in Ontario dairy herds

Data collected from 297 dairy farms in Ontario were analyzed to investigate the economic consequences of using dry-cow antibiotic therapy, and to demonstrate the elements of an economic evaluation. Benefit/cost ratios ranged from 0.5 to 31.0 depending on the methods used to assess the benefits of therapy. In general, within the assumptions outlined in this analysis, dry-cow therapy was found to be economically advantageous. However, many factors can influence milk production and somatic cell counts. In this observational study, it is possible that some such factors were confounded with the use of dry-cow therapy, and may have biased the estimates of economic impact.